These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 30864272

  • 21. Epstein-Barr virus-associated multifocal leiomyosarcomas arising in a cardiac transplant recipient: autopsy case report and review of the literature.
    Nur S, Rosenblum WD, Katta UD, Islam H, Brown K, Ramaswamy G.
    J Heart Lung Transplant; 2007 Sep; 26(9):944-52. PubMed ID: 17845934
    [Abstract] [Full Text] [Related]

  • 22. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey.
    San-Juan R, Manuel O, Hirsch HH, Fernández-Ruiz M, López-Medrano F, Comoli P, Caillard S, Grossi P, Aguado JM, ESGICH PTLD Survey Study Group,, European Study Group of Infections in Compromised Hosts (ESGICH) from the European Society of Microbiology and Infectious Diseases (ESCMID).
    Clin Microbiol Infect; 2015 Jun; 21(6):604.e1-9. PubMed ID: 25686696
    [Abstract] [Full Text] [Related]

  • 23. Brain involvement in multicentric Epstein-Barr virus-associated smooth muscle tumours in a child after kidney transplantation.
    Boudjemaa S, Boman F, Guigonis V, Boccon-Gibod L.
    Virchows Arch; 2004 Apr; 444(4):387-91. PubMed ID: 15143769
    [Abstract] [Full Text] [Related]

  • 24. Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients.
    Liu M, Husain S, Famure O, Li Y, Kim SJ.
    Prog Transplant; 2019 Jun; 29(2):185-193. PubMed ID: 30845885
    [Abstract] [Full Text] [Related]

  • 25. Epstein-Barr Virus-Associated Pulmonary Smooth Muscle Tumor After Lung Transplantation.
    Brescia AA, Khullar OV, Gal AA, Neujahr D, Force SD.
    Ann Thorac Surg; 2015 Jun; 99(6):e145-6. PubMed ID: 26046906
    [Abstract] [Full Text] [Related]

  • 26. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV.
    Transplantation; 2012 Jan 15; 93(1):73-81. PubMed ID: 22129761
    [Abstract] [Full Text] [Related]

  • 27. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
    Bakker NA, Verschuuren EA, Erasmus ME, Hepkema BG, Veeger NJ, Kallenberg CG, van der Bij W.
    Transplantation; 2007 Feb 27; 83(4):433-8. PubMed ID: 17318076
    [Abstract] [Full Text] [Related]

  • 28. Role of surgery in treating epstein-barr virus-associated smooth muscle tumor (EBV-SMT) with central nervous system invasion: A systemic review from 1997 to 2019.
    Lau KW, Hsu YW, Lin YT, Chen KT.
    Cancer Med; 2021 Mar 27; 10(5):1473-1484. PubMed ID: 33576167
    [Abstract] [Full Text] [Related]

  • 29. Synchronous Epstein-Barr virus-associated skull base and adrenal smooth-muscle tumors in an 8-year-old girl with recent Epstein-Barr virus infection.
    Brown DA, Deep NL, Driscoll CL, Link MJ, Jentoft ME, Daniels DJ.
    J Neurosurg Pediatr; 2018 Sep 27; 22(3):283-287. PubMed ID: 29905497
    [Abstract] [Full Text] [Related]

  • 30. Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative Disorder.
    Sen A, Enriquez J, Rao M, Glass M, Balachandran Y, Syed S, Twist CJ, Weinberg K, Boyd SD, Bernstein D, Trickey AW, Gratzinger D, Tan B, Lapasaran MG, Robien MA, Brown M, Armstrong B, Desai D, Mazariegos G, Chin C, Fishbein TM, Venick RS, Tekin A, Zimmermann H, Trappe RU, Anagnostopoulos I, Esquivel CO, Martinez OM, Krams SM.
    Front Immunol; 2022 Sep 27; 13():994552. PubMed ID: 36304469
    [Abstract] [Full Text] [Related]

  • 31. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
    Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Sack FU, Schnabel P, Schnitzler P, Katus HA, Dengler TJ.
    Transpl Int; 2008 Oct 27; 21(10):963-71. PubMed ID: 18564989
    [Abstract] [Full Text] [Related]

  • 32. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.
    Martinez OM, Krams SM.
    Transplantation; 2017 Sep 27; 101(9):2009-2016. PubMed ID: 28376031
    [Abstract] [Full Text] [Related]

  • 33. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 27; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 34. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 27; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 35. Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.
    Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R.
    Clin Transplant; 2017 Jul 27; 31(7):. PubMed ID: 28383790
    [Abstract] [Full Text] [Related]

  • 36. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
    Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T.
    Transpl Infect Dis; 2016 Feb 27; 18(1):44-54. PubMed ID: 26574232
    [Abstract] [Full Text] [Related]

  • 37. Two cases of post transplant lymphoproliferative disorder in lung transplant recipients.
    Chang YS, Kim Y, Kim DY, Kim HJ, Ahn CM, Lee DY, Paik HC.
    Korean J Intern Med; 2004 Dec 27; 19(4):276-81. PubMed ID: 15683119
    [Abstract] [Full Text] [Related]

  • 38. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

  • 39. Increased risk of PTLD in lung transplant recipients with cystic fibrosis.
    Lowery EM, Adams W, Grim SA, Clark NM, Edwards L, Layden JE.
    J Cyst Fibros; 2017 Nov 15; 16(6):727-734. PubMed ID: 28456611
    [Abstract] [Full Text] [Related]

  • 40. Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.
    Köpf S, Tönshoff B.
    Pediatr Nephrol; 2004 Apr 15; 19(4):365-8. PubMed ID: 14963763
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.